Abiopharma

📋 Congleton Jon (Officer) plans to sell 16K shares of Mineralys Therapeutics, Inc. (at $32.62 each, total $530K) Filed: Jan 12, 2026 | ID: 000036

Andrews Brian G 🟡 adjusted position in 1.9K shares (1 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001

(90% Positive) Exelixis Inc (EXEL) Announces Enrollment Update for results Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Director Kaye Jack 🟡 adjusted position in 6.4K shares (1 derivative) of uniQure N.V. (QURE) at $27.28 Transaction Date: Jan 09, 2026 | Filing ID: 000013

📋 Nagendran Sukumar (Officer) plans to sell 200K shares of Taysha Gene Therapies, Inc. (at $4.98 each, total $996K) Filed: Jan 12, 2026 | ID: 000011

Lippoldt Darin 🟡 adjusted position in 0 shares (1 derivative) of NEUROCRINE BIOSCIENCES INC (NBIX) at $35.99 Transaction Date: Jan 08, 2026 | Filing ID: 000004

New Form 3 - Outset Medical, Inc. Filed: 2026-01-12 AccNo: 0000905148-26-000142 Size: 11 KB

(99% Neutral) Dynatronics Corp. (DYNT) Announces New Board Appointment

Assertio Holdings, Inc. - Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Revvity - Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

BD To Host Virtual 2026 Annual Meeting of Shareholders

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Taiwan Carbon Nano Technology Corp 🔴 sold 1.3K shares of Ainos, Inc. (AIMD) at $1.86 Transaction Date: Jan 08, 2026 | Filing ID: 001852